Your session is about to expire
← Back to Search
Mobile Contingency Management for Smoking Cessation
N/A
Waitlist Available
Led By Darla Kendzor, PhD
Research Sponsored by University of Oklahoma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 13 weeks post-enrollment
Awards & highlights
Study Summary
This study is evaluating whether a new approach to mobile phone based contingency management may help individuals quit smoking.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 13 weeks post-enrollment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~13 weeks post-enrollment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Completion of Breath Sample Submissions
Self-Reported Smoking Cessation
Secondary outcome measures
Loss of Smartphones
Loss of iCO Sensors
Side effects data
From 2019 Phase 4 trial • 35 Patients • NCT0242001514%
Sleep problems and/or nightmares
14%
Mouth and/or throat irritation
14%
Suicidal ideation
10%
Jitteriness, shakiness
10%
Nausea, upset stomach
10%
Flu
10%
Skin irritation
10%
Family violence
10%
Hospitalization
5%
dizziness
5%
Asthma
5%
Sweating
5%
Increased seizures
5%
Car accident
5%
Increased psychiatric symptoms
5%
Dental surgery
5%
Increased foot pain
5%
Benign tumor removed from lung
5%
Pain
100%
80%
60%
40%
20%
0%
Study treatment Arm
iCOMMIT
Control Group
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Mobile Contingency ManagementExperimental Treatment2 Interventions
Group II: Standard CareActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mobile Contingency Management
2017
Completed Phase 4
~120
Standard Care
2018
Completed Phase 4
~3720
Find a Location
Who is running the clinical trial?
National Cancer Institute (NCI)NIH
13,658 Previous Clinical Trials
40,924,467 Total Patients Enrolled
University of OklahomaLead Sponsor
455 Previous Clinical Trials
97,590 Total Patients Enrolled
Darla Kendzor, PhDPrincipal InvestigatorUniversity of Oklahoma
4 Previous Clinical Trials
124 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger